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Abstract
Bacterial virulence is a multifaceted trait where the interactions between pathogen and host
factors affect the severity and outcome of the infection. Toxin secretion is central to the biol-
ogy of many bacterial pathogens and is widely accepted as playing a crucial role in disease
pathology. To understand the relationship between toxicity and bacterial virulence in greater
depth, we studied two sequenced collections of the major human pathogen Staphylococcus
aureus and found an unexpected inverse correlation between bacterial toxicity and disease
severity. By applying a functional genomics approach, we identified several novel toxicity-
affecting loci responsible for the wide range in toxic phenotypes observed within these col-
lections. To understand the apparent higher propensity of low toxicity isolates to cause bac-
teraemia, we performed several functional assays, and our findings suggest that within-host
fitness differences between high- and low-toxicity isolates in human serum is a contributing
factor. As invasive infections, such as bacteraemia, limit the opportunities for onward trans-
mission, highly toxic strains could gain an additional between-host fitness advantage,
potentially contributing to the maintenance of toxicity at the population level. Our results
clearly demonstrate how evolutionary trade-offs between toxicity, relative fitness, and trans-
missibility are critical for understanding the multifaceted nature of bacterial virulence.
Author Summary
Global efforts to counter the growing problem of antibiotic resistance and develop alterna-
tive treatment strategies rely on a fuller understanding of when and why opportunistic
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pathogens cause disease. Recent advances in DNA sequencing technologies have opened
up new opportunities to study infectious organisms, yet identifying the genetic variants
that explain differences in disease remains challenging. Here we aimed to understand the
complex relationship between toxicity—a known risk factor for disease in many bacteria—
and infection severity for the major human pathogen S. aureus. Against expectations, we
found that the bacteria that caused the most severe disease were the least toxic strains. We
were able to determine the mutations responsible for the differences in toxicity and identi-
fied a number of novel toxicity-affecting genes. We further discovered that bacterial fitness
in human serum could explain the unexpected association of low-toxicity isolates with
severe, invasive disease. Invasive S. aureus infections are usually considered a dead end for
these bacteria, as these infections are rarely transmitted to another person. Here we show
using a simple mathematical model that this might in fact favour transmission of highly
toxic bacteria on a population level and thus contribute to their global success. Our work
therefore highlights the complexity of bacterial infection and should aid in devising new
treatment and control strategies against this important pathogen.
Introduction
The development of effective, long-term control strategies against microbial pathogens cru-
cially relies on a thorough understanding of the many factors that contribute to the evolution
and maintenance of enhanced virulence. Bacterial toxins are well established as playing a key
role in virulence [1–4]. They release nutrients for bacterial growth and facilitate intra- and
interhost transmission by destroying local tissue and subverting host immune processes [5–7].
This has led to the general presumption that elevated toxicity is positively associated with
enhanced disease severity in bacterial infections [5,8,9]. However, the expression of toxins is
readily switched off in vitro in response to the selection imposed by the energetically costly
nature of their production [10,11]. Observational studies in S. aureus suggest that this can also
occur in vivo, indicating that the relationship between toxicity and disease severity is more
complex than initially appreciated [12–17].
S. aureus is a major human pathogen and a global healthcare issue. It is considered opportu-
nistic as it asymptomatically colonises its host but can occasionally cause diseases that range in
severity from relatively minor skin and soft tissue infections (SSTI) to life-threatening cases of
pneumonia and bacteraemia [9]. Toxicity has been accepted as playing a key role in the success
of lineages such as USA300 [18] and ST93 [19], in which it has been suggested to increase
transmissibility. Toxicity is also widely accepted as playing a significant role in the virulence of
S. aureus, where many studies comparing high- and low-toxicity isolates in animal models of
sepsis show that highly toxic isolates cause more severe disease symptoms [20–24]. However, it
has recently been shown that S. aureus isolates from humans with invasive diseases, such as
bacteraemia and pneumonia, are often impaired in their ability to express toxins (often referred
to as Agr dysfunction) [12,13]. A strength of the collections of isolates considered in these stud-
ies is that they represent all of the isolates presenting in a given geographical region over a
defined period of time. Unfortunately, this type of sampling brings with it a limitation, as such
collections consequently also contain a wide range of genetic backgrounds and antibiotic resis-
tance profiles that might confound any potential associations between toxicity and disease.
In this study, we applied a robust functional genomics approach to two collections of S.
aureus isolates, with significant depth and breadth, where we have controlled for genetic back-
ground by sampling within specific clinically important lineages, including USA300. Our
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approach not only allowed us to make observations that challenge our understanding of the
role of toxicity in the establishment of severe, invasive disease but also to identify the genetic
polymorphisms involved. By using a combination of functional assays, we further identified
bacterial fitness in human serum as an important factor that could limit the ability of highly
toxic isolates to cause bacteraemia and would explain the observed negative relationship
between toxicity and disease severity. The power of genomics to study past events is clear, and
here we demonstrate its potential to also help us understand fundamental aspects of bacterial
pathogenicity and their role in invasive disease.
Results
To determine the relationship between toxicity and disease for S. aureus, we performed a
detailed investigation of two large collections of fully sequenced clinical isolates representing
significant breadth and depth of sampling (S1 Table). The first collection (ST15, PVL-, MSSA)
was isolated from a single patient who progressed from asymptomatic carriage to bacteraemia
over a 15-mo period [25]. The second, a collection of 134 clinical isolates, all corresponding to
a single clone (USA300, ST8, PVL+, SCCmec type IV MRSA) and isolated from the nose or
skin of healthy volunteers (carriage), from SSTI or from bacteraemic patients [26].
Reduced Toxicity Associates with Invasive Disease
The single-patient collection included serial asymptomatic nasal carriage isolates over a 12-mo
period, as well as bloodstream isolates after bacteraemia had developed at month 15 [25]. At
each time point, 12 individual colonies were isolated from the primary plates for each swab.
These isolates all belong to the ST15 lineage and contain genes for 12 of the 13 known cytolytic
toxins secreted by S. aureus (i.e., alpha, beta, gamma, delta, LukAB, LukED, PSMα1, α2, α3,
α4, β1, β2, but not LukSF [a.k.a. Panton-Valentine-leukocidin or PVL]). To quantify the gross
cytolytic activity of each isolate, we used an immortalised T/B hybridoma cell line (T2), which
is susceptible to 10 of the 12 cytolytic toxins present in this collection (not LukAB or LukED)
(S1 Fig). Despite some sequence variability across the 12 isolates from each time point and
between the different time points [25], no diversity in toxicity was observed for the early nasal
culture isolates (Fig 1A). At month 12, however, there was a significant drop in toxicity for all
12 nasal carriage colonies, shortly after which the study participant developed bacteraemia
(month 15). The bacteria isolated from the patient’s bloodstream also showed significantly
reduced toxicity compared to those from the earlier time points (Fig 1A), demonstrating an
apparent inverse correlation between toxicity and disease, albeit in a sample size of only one
patient.
To ensure this effect was not a consequence of the lack of sensitivity of the T2 cell line to
LukAB and ED, we quantified the ability of a subset of six high- and six low-toxicity isolates (as
determined using the T2 cells) to lyse freshly harvested human neutrophils, which are sensitive
to LukAB and LukED. We found that the isolates that were unable to lyse the T2 cells were also
unable to lyse the neutrophils (S1 Fig), suggesting that LukAB and LukED were not expressed
by these low-toxicity isolates, and that the T2 cell line provides a robust measure of gross cyto-
lytic activity for this collection of isolates.
Having demonstrated a negative correlation between toxicity and disease for a single
patient, we sought to extend this to multiple patients by focussing on a collection of 134
USA300 MRSA isolates. As the USA300 lineage is known to contain the genes encoding the
LukSF (i.e., PVL) toxin we included a human monocytic cell line, THP-1, which is sensitive to
the action of this toxin [27]. In this set of isolates, we again found that the bacteraemic isolates
were significantly less toxic than either the carriage or the SSTI groups (Fig 1B and 1C,
Staphylococcus aureus Toxicity Virulence
PLOS Biology | DOI:10.1371/journal.pbio.1002229 September 2, 2015 3 / 21
Fig 1. Low levels of toxicity are associated with invasive S. aureus infections across two collections
of clinical isolates. a: Individual isolates from seven time points were assayed for toxicity and their genome
sequenced. Early nose cultures (ENCs) frommonths 1, 2, 4, 6, and 8 were all highly toxic. Late nose culture
(LNC) isolates at month 12 and bloodstream isolates following bacteraemia (late blood culture, LBC) were all
significantly less toxic than the ENC isolates. b and c: The toxicity of 134 USA300 isolates were assayed,
and those from bacteraemia were on average significantly less toxic (measured as percent T2 and THP1 cell
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ANOVA: p< 0.01 for both T2 cells and THP-1 cells). With these two collections of isolates,
representing both broad sampling across patients and deep sampling within a patient, we dem-
onstrate a significant negative association between toxicity and disease severity.
Polymorphisms in a Range of Loci Affect the Toxicity of S. aureus
The single-patient collection contained only a small number of genetic differences between the
isolates, and as such we were readily able to identify the genetic basis of the change in toxicity.
We found that the late nasal carriage and blood culture isolates had a premature stop-codon in
an araC-like transcriptional regulator gene rsp, which encodes a protein that has previously
been shown to regulate biofilm formation by this pathogen [28]. Using a transposon insertion
in the rsp gene (NE1304) from the Nebraska library [29], we found a significant reduction in
toxicity compared to the wild-type strain (Fig 2), thus verifying this gene’s toxicity-regulating
function. Interestingly, mutating the rsp gene with a transposon in the USA300 (ST8) back-
ground (Fig 2) did not have as significant an effect on toxicity as the stop-codon in the ST15
background (Fig 1A), presumably as a consequence of differences in the genetic background of
these bacterial clones.
To identify the genetic polymorphisms responsible for the changes in toxicity of the
USA300 isolates, we adopted a functional genomics approach using genome-wide association
studies (GWAS) to identify candidate polymorphisms associated with toxicity (S2 Table). As
GWAS is prone to high false positive rates, we sought to verify the effect of the associated loci
using transposon insertions in each locus that was available from the Nebraska library (the full
list of significantly associated polymorphisms can be found in S2 Table). We identified five
novel toxicity-affecting loci (Fig 2): ftsK, clpC, sucD, rpsA, plus a hypothetical gene with no
known activity or homology to other proteins (SAUSA300_0750). Based on amino acid homol-
ogy, the FtsK protein is believed to be a DNA translocase, where polymorphisms have also
been associated with changes in the toxicity of another globally successful MRSA clone, ST239
[30]. FtsK also shares significant structural similarities to transporters, suggesting that this pro-
tein may be directly involved in the secretion of toxins from the bacterial cell, rather than DNA
translocation. The ClpC protein is a chaperone and has been shown previously to affect the
expression of a large number of proteins, including several regulators of toxin expression [31].
The role of the proteins encoded by sucD (succinyl-CoA synthetase subunit alpha) and rpsA
(30S ribosomal protein S1) in toxin expression is less clear, although any changes to the metab-
olism of a cell are likely to have significant downstream effects on gene expression [32]. Further
work is underway to elucidate the molecular detail of how these proteins affect toxicity.
Explaining the Association between Toxicity and Infection Severity
A) Underlying health of patient. It is possible that the less toxic isolates are more often
associated with bacteraemia because of the presence of comorbidities associated with an
impaired immune system that might result in failure to control less toxic organisms. Although
we cannot fully discount this, when we examined the relatedness of these isolates by mapping
the isolate source and level of toxicity onto a maximum likelihood tree based on their genome
sequence (Fig 3), despite some clustering of the bacteraemic isolates, they are distributed across
the tree and are often closely related to highly toxic carriage or SSTI isolates. This suggests that
death (b and c, respectively)) than from carriage or SSTI (p < 0.01 ANOVA). The medians are presented as
horizontal bars, with the boxes and whiskers showing the 1st and 3rd quartile and interquartile ranges. To
access this data, see S1 Data.
doi:10.1371/journal.pbio.1002229.g001
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a susceptible patient would be just as or more likely to be exposed to a highly toxic as to a low
toxicity isolate. A retrospective chart review (summarised in S3 Table) also found no associa-
tions between the presence of suspected portals of entry, types of suspected portals of entry, or
length of bacteraemia with the toxicity of the isolates. While the health of the patient is
undoubtedly a factor in their susceptibility to the development of bacteraemia, where the dam-
age-response framework is clearly implicated [33], it does not explain why patients are more
likely to develop invasive diseases with the less toxic isolates.
B) Cell-invasive capacity. The regulation of toxin secretion by S. aureus has been well
studied under laboratory conditions [34,35], where they are known to phenotypically switch
between their ability to attach to and invade human cells and their ability to secrete toxins. We
therefore hypothesised that the more toxic isolates might be impaired in their ability to invade
human cells, causing them to be less able to gain entry to the bloodstream. To test this hypothe-
sis, we quantified the ability of 10 high- and 10 low-toxicity isolates to invade a human-derived
endothelial cells line (EA.hy926) and found no differences in cell-invasive capacity between
high- and low-toxicity isolates (Fig 4B).
C) The release of neutrophil extracellular traps (NETs). Another feature of the ability of
S. aureus to cause disease is their immune evasive capacity. Neutrophils are of particular
importance in immunity to S. aureus infection, and of the many roles they play, their ability to
trap bacteria in NETs has been shown to be triggered by cytolytic toxins [36]. We therefore
Fig 2. The identification of six novel toxicity-affecting loci. Transposonmutagenesis was used to functionally verify the role of loci associated with toxicity
by genome-wide association study (GWAS; PLINK). Mean of six replicates are presented, error bars represent the 95% confidence intervals. The mutation in
agrB is provided as a negative control. To access this data, see S2 Data.
doi:10.1371/journal.pbio.1002229.g002
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hypothesised that neutrophils in the bloodstream might be more efficient at trapping the more
toxic isolates, impeding their ability to establish an infection in the bloodstream. However,
when we compared the ability of 10 high- and 10 low-toxicity isolates to induce neutrophil net
formation, while we observed significant differences between individual isolates, this was unre-
lated to their toxicity (Fig 4C).
D) Protease activity. As the secretion of proteases by S. aureus also causes significant tis-
sue damage, we hypothesised that the more toxic isolates might be less proteolytic, and this
could impede their ability to cause bacteraemia. To test this, we assayed the protease activity of
10 high- and 10 low-toxicity isolates; however, no significant difference in protease activity
between these collections of isolates was observed (Fig 4D)
E) Antimicrobial peptide resistance. A fundamental aspect of host innate immunity that
provides protection from bacterial infection is the secretion of antimicrobial peptides. We
hypothesised that the more toxic isolates may be less resistant to the effect of these, which
Fig 3. Toxicity levels and disease origin distributed across the USA300 collection. The clinical origin (carriage = C, SSTI = S, or blood = B) and the
toxicity (low = green, medium = orange or high = red) of 134 USA300 isolates are mapped onto a maximum likelihood tree based on their whole genome
sequence.
doi:10.1371/journal.pbio.1002229.g003
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Fig 4. Explaining the association between toxicity and infection severity. A range of virulence assays were performed on a subset of 10 high- and 10
low-toxicity isolates from the USA300 collection to identify the biological feature that explains the observed inverse correlation between toxicity and disease
severity. (A) The toxicity of the subset of isolates is provided for comparison. (B) The ability of the bacteria to invade EA.hy926 endothelial cells. (C) The
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would impede their ability to cause bacteraemia. To test this, we measured the percentage sur-
vival of a subset of 10 high- and 10 low-toxicity isolates following incubation with 5 μg/mL
human neutrophil defensin-1 (hNP-1), but no significant difference between these collections
of isolates was observed (Fig 4E)
F) Biofilm formation. As biofilm formation by S. aureus is believed to contribute to their
ability to colonise both biotic and abiotic surfaces, we hypothesised that the high toxicity iso-
lates may be less able to form biofilm, impeding their ability to cause bacteraemia. To test this,
we quantified the ability of 10 high- and 10 low-toxicity isolates to form biofilms; however, no
difference between the high and low toxicity isolates was observed (Fig 4F).
G) Relative fitness in human serum. The bloodstream is a highly protected niche. With
almost all elements of host immunity present, it acts as a severe bottleneck for the bacteria, as
evidenced by the lack of genetic diversity amongst the isolates from bacteraemic patients (we
found no genetic diversity amongst them, despite the 12 isolates having been sampled at two
time points and collected in three bottles). Serum contains many antimicrobial peptides and
has been shown in two previous studies to have the effect of both increasing the expression of
toxins [37,38] and neutralising their activity simultaneously [39]. As toxin expression is widely
accepted as being an energetically costly activity, we hypothesised that the fitness costs associ-
ated with the up-regulation of toxin expression in blood could be sufficient to reduce the prob-
ability of the highly toxic isolates from getting through the bottleneck and establishing a blood
stream infection. We therefore compared the growth dynamics and relative fitness of six high-
and six low-toxicity isolates from the single-patient collection and 10 high- and 10 low-toxicity
isolates from the USA300 collection in brain–heart infusion broth (BHI) and in BHI supple-
mented with 5% human serum. Although 5% serum had significant antibacterial activity on
these isolates (S2 Fig and S6 Data), we observed no difference in growth dynamics of the high
and low toxicity isolates. However, when we measured the relative fitness of the isolates, which
is more sensitive to growth defects, we found that in BHI the high-toxicity isolates from both
collections were slightly less fit than the low-toxicity isolates, although not statistically signifi-
cant (p = 0.19 and 0.28 respectively, Fig 5A and 5B). However, when serum was added, which
has the effect of increasing toxin expression further, the difference in relative fitness between
the high- and low-toxicity isolates was significantly increased for both collections (p = 0.003
and 0.02 respectively, Fig 5A and 5B).
To support our hypothesis that the effect on fitness is due to levels of toxin expression, we
ensured that the low-toxicity isolates all had SNPs in a wide range of loci (including rsp, ftsK,
clpC, sucD, rpsA, and SAUSA300_0750), and further included an Agr wild type and mutant
isogenic pair (Fig 5A–5C). Regardless of the locus affected, once toxicity was lowered, relative
fitness was increased upon exposure to serum.
The Observed Association between Low Toxicity and Bacteraemia May
Contribute to the Maintenance of High Toxicity at a Population Level
With mortality rates as high as 20% for S. aureus bacteraemia [40], understanding how these
types of infections develop is of significant clinical importance. However, as the bacteria rarely
transmit beyond this point, they can be effectively thought of as transmission dead ends. We
therefore sought to explore the possible evolutionary effect of the observed association of low-
ability of the bacteria to induce the release of neutrophil extracellular traps (NETs). (D) The release of proteases by the bacteria. (E) Resistance of the
bacteria to human neutrophil defensin-1. (F) The ability of the bacteria to form biofilms. The p-value for the comparison between the high and low toxicity
isolates was greater than 0.05 for all traits with the exception of toxicity. The medians are presented as horizontal bars, with the boxes and whiskers showing
the 1st and 3rd quartile and interquartile ranges. To access this data see S3 Data.
doi:10.1371/journal.pbio.1002229.g004
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toxicity isolates with invasive infections using a simple mathematical model (see Methods). We
considered two competing strains of S. aureus that differed in their level of toxicity, where
higher toxicity was assumed to be positively correlated with transmissibility and progression
from carriage to SSTI, based on the fact that we rarely find low-toxicity isolates amongst our
carriage or SSTI populations, and that low-toxicity mutants have been rarely found to transmit
amongst healthy populations [17]. But higher toxicity also resulted in faster treatment. With
this, we examined what effect the strains’ relative propensity to cause bacteraemia (σ) had on
their competitive fitness.
Assuming no differences (σl = σh, Fig 6A and 6B and S3 Fig), we find that the higher clear-
ance rate of the more toxic strain offsets its transmission advantage, leading to its exclusion
and dominance of the less toxic strain (shown separately for carriage and SSTI and bacteraemia
in Fig 6A and 6B, respectively). In contrast, considering the clinically observed negative associ-
ation of toxicity with bacteraemia (σl> σh) results in the more toxic strain gaining a competi-
tive advantage at the population level (carriage and SSTI, Fig 6C, S3 Fig and S4 Fig), whereas
the less toxic strain maintains its elevated frequency during bacteraemia (Fig 6D, S3 Fig and S4
Fig), in line with clinical observations. This suggests that the reduced opportunity for transmis-
sion due to bacteraemia could partly compensate for the toxicity-driven trade-off between
transmissibility and treatment rates and thus contribute to the maintenance and circulation of
highly toxic strains within the population.
Discussion
For microbial pathogens, many factors contribute to their success, but for an opportunistic
pathogen that can either reside asymptomatically or cause symptomatic infections ranging
from superficial to life-threatening invasive disease, the definition of success becomes increas-
ingly complex. The damage-response framework outlines the necessary holistic approach we
need to take when considering this, where both the level of virulence expressed by the pathogen
and the response of the host is critical to the clinical outcome [33]. For S. aureus, the vast
majority of infections resolve without clinical intervention, and severe infections (e.g., bacterae-
mia or pneumonia) are generally limited to those with compromised health [9]. With many
genes encoding cytolytic toxins, and highly toxic clones disseminating worldwide, it is under-
standable that toxicity and virulence have long been considered directly linked and key to its
success. However, here we show this relationship to be quite complex.
The boom in genomic sequence data for microbial pathogens has allowed us to study past
genetic events in great detail, tracing epidemics and studying how bacterial genomes evolve
[25,41–44]. It is, however, only recently that we have been able to successfully use such geno-
mic data to study the behaviour of pathogens and use functional genomics approaches to
understand why and how specific traits evolve [30,45–49]. By studying two large collections of
isolates, we demonstrate that bacteraemic isolates are significantly less toxic than those isolated
from carriage or from SSTIs. With the genome sequence of each isolate available to us, we were
able to identify the polymorphisms responsible for the observed changes in toxicity and in
doing so have identified six novel toxicity-affecting loci for this pathogen. A molecular
Fig 5. The highly toxic isolates are less fit than the low-toxicity isolates in the presence of human
serum.We quantified the relative fitness of six high- and six low-toxicity isolates from the single patient
collection (A), 10 high- and 10 low-toxicity isolates from the USA300 collection (B) and an Agr wild type and
mutant isogenic pair (C) in BHI with and without 5% (vol/vol) human serum. The medians are presented as
horizontal bars, with the boxes and whiskers showing the 1st and 3rd quartile and interquartile ranges.
p-values are indicated in the text. To access this data, see S4 Data.
doi:10.1371/journal.pbio.1002229.g005
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dissection of each locus is currently underway to determine how they affect this trait, but this
work clearly demonstrates the power of functional genomics for studying bacteria.
To understand why low toxicity isolates have a higher propensity to cause bacteraemia, we
developed and tested several hypotheses. While the health of a patient is a feature in their sus-
ceptibility to bacteraemia, we were unable to find evidence to suggest that this would increase
their propensity to develop bacteraemia with a low rather than a highly toxic isolate. Further-
more, we found no evidence suggesting that either cell-invasiveness, NET formation, protease
activity, antimicrobial peptide resistance, or biofilm formation play a role. Instead, we found
that the presence of serum, which simultaneously increases toxin expression while neutralising
their activity, reduces the relative fitness of the highly toxic isolates. Given the extreme bottle-
neck that the establishment of a bloodstream infection represents to bacteria, we believe this
explains our finding that low-toxicity isolates are a more common cause of this type of invasive
Fig 6. Evolution towards increased levels of virulence. Two competing MRSA strains with different levels of toxicity are considered, where higher toxicity
is assumed to increase the transition rate from carriage to infection (SSTI) but also increases treatment-induced clearance of infections. At baseline, we
assume that both strains have equal propensities to cause severe bacteraemia (σl = σh), which causes the more toxic strain (red) to be outcompeted due to
its faster, virulence-induced clearance rates and leads to the dominance of the less toxic strain (green) both at carriage + SSTI (a) and at bacteraemic stage
(b). By considering a negative correlation between toxicity and bacteraemia (σl > σh), the more toxic strain gains a competitive advantage, leading to higher
frequencies at carriage and SSTI stages (c). However, the higher propensity of the less toxic strain, in this case maintained in the population through
mutational down-regulation from highly toxic strains, maintains its high frequency at the bacteraemic stage (d). See Methods for parameter values.
doi:10.1371/journal.pbio.1002229.g006
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disease. By use of a mathematical model, we also showed that this increased propensity for
low-toxicity isolates to cause bacteraemia, alongside the dead end nature of such infections,
could potentially contribute to the maintenance of high levels of toxicity at a population level,
as evidenced by the global prevalence of highly toxic clones, such as USA300 and ST93.
To understand the relative efficiency of GWAS to identify novel toxicity-affecting loci, we
need to compare it to a similar experiment that used a random approach. Fey et al., who cre-
ated the transposon library used here, screened their 1952 Tn mutants for haemolytic activity
using rabbit blood agar plates and identified 71 mutants with a change in this phenotype [29].
Compare this hit rate of 3.6% with ours of 6.7% and the relative efficiency of this GWAS
approach is apparent. This efficiency is, however, significantly affected by the size and related-
ness of the isolates within the collection; as in a previous GWAS study, we used a more closely
related collection of isolates and had a hit rate of 30% [30]. Such issues need to be considered
when designing GWAS experiments for bacteria.
This work highlights a clear limitation to existing animal models of infection for pathogens
like S. aureus. Studies published by us and many other groups have shown that in sepsis mod-
els, highly toxic isolates cause a more severe infection in mice than less toxic isolates [20–24],
which would seem contrary to our findings here in humans. However, a major difference
between these two systems needs to be considered. For humans, studies have demonstrated
that bacteraemia represents an extreme bottleneck, with only a small number of cells being suf-
ficient to cause disease [25,50]. For mice, on the other hand, 107–108 colony-forming units
need to be injected directly into the tail vein to get reproducible infections, which overrides the
rigours bacteria need to go through to cause bacteraemia naturally in human. Furthermore,
subtle differences in relative fitness, which we suggest contribute to our clinical observations,
would not be evident in a mouse overwhelmed with the introduction of so many bacteria cells
directly into its bloodstream. We would therefore urge caution when interpreting the results
from such experiments in relation to human disease.
It is interesting to note that no difference in toxicity was observed between the carriage iso-
lates and those causing SSTIs, and that, on average, both groups were highly toxic. Many ani-
mal models have been used to demonstrate that the size of a cutaneous lesion is greatly affected
by the levels of toxins secreted by the infecting organism [5]. While we have no clinical data to
compare toxicity levels and lesion size for these isolates, that we rarely find low-toxicity isolates
causing SSTIs supports the findings from animal models that toxicity correlates with the ability
to cause such lesions. It is also intriguing to consider what selective forces maintain such a high
level of toxicity at a population level. For symptomatic transmission, the toxin-induced pro-
duction of highly transmissible pus has obvious benefits. However for asymptomatic transmis-
sion, this is less obvious. Low toxicity isolates can survive in the nose, as indicated by the single
patient collection where the low toxicity isolates survived there for 3 mo before causing bacter-
aemia. However, perhaps over a longer term, the ability of highly toxic bacteria to resist the
effects of nasal-associated immunity by killing host immune cells, and the use of some toxins
(e.g., the phenol soluble modulins, PSMs) to interfere with competing genera of bacteria, is key
to its maintained selection.
For S. aureus, an opportunistic pathogen, it is clear that virulence is multifaceted. On the
one hand, the prevalence of highly toxic clones globally and the role of specific toxins in caus-
ing highly transmissible pus-filled SSTI lesions suggests that toxins offer a selective advantage.
On the other hand, it appears that offsetting toxicity for short-term enhanced fitness is associ-
ated with increased virulence, which may paradoxically select for the maintenance of higher
levels of toxicity at a population level. Although at a superficial level these seem contradictory,
it is clear that they are critical aspects of this pathogen’s success. With the movement of
genome sequencing into routine clinical practice and the drive towards personalised medicine,
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we need to define these complex interactions and bring the biology of the pathogen into greater
consideration in clinical settings.
Materials and Methods
Ethics Statement
Whole blood was obtained from healthy volunteers; ethical permission for all donations was
obtained from local research ethics committee (School of Pharmacy & Pharmaceutical Sciences
Ethics Committee) and all participants gave written informed consent.
Bacterial Strains and Growth Conditions
A list of the bacterial strains used can be found in S1 Table. For the toxicity assays, the S. aureus
isolates were grown overnight in 5 mL of Tryptic-Soy Broth (TSB) in a 30 mL glass tube. This
overnight culture was used to inoculate the toxicity-assay cultures at 1:1,000 dilution in fresh
TSB and then grown for 18 h at 37°C in air with shaking (180 rpm). For transposon mutants,
erythromycin (5 μg/mL) was included in the growth medium. The toxin-containing superna-
tant for each isolate was harvested by centrifugation.
T2 and THP-1 Toxicity Assay
Immortalised human T2 cells and monocyte macrophage THP-1 cell lines were used as
described previously [51]. The THP-1 cell line was included for the USA300 collection as it is
susceptible to the PVL [27]. Briefly, both cell lines were grown in individual 30 mL suspensions
of RPMI-1640, supplemented with 10% heat-inactivated fetal bovine serum (FBS), 1 μM L-glu-
tamine, 200 units/mL penicillin, and 0.1 mg/mL streptomycin at 37°C in a humidified incuba-
tor with 5% CO2. Cells were routinely viewed microscopically every 48–60 h and harvested by
centrifugation at 1,000 rpm for 10 min at room temperature and resuspended to a final density
of 1–1.2 x 106 cells/mL in tissue-grade phosphate buffered saline. This procedure typically
yielded>95% viability of cells as determined by trypan blue exclusion and easyCyte flow
cytometry. To monitor S. aureus toxicity, 20 μL of cells were incubated with 20 μL of bacterial
supernatant and incubated for 12 min at 37°C. For the USA300 strains, supernatants were
diluted to 30% of the original volume in TSB as these isolates were considerably more toxic
than the single-patient isolates. Cell death was quantified using easyCyte flow cytometry using
the Guava viability stain according to manufacturer’s instructions. Experiments were done in
triplicate, and error bars indicate the average ± the 95% confidence interval of multiple inde-
pendent experiments.
GWAS
The identification of genetic variation in all the clinical isolates studied has previously been
described [25,26] with the exception of the 36 bacteraemic USA300 isolates. These were
sequenced in an identical manner to the others; namely, genomic DNA was extracted using the
QIAamp DNAMini Kit (Qiagen), and unique index-tagged libraries were generated. Whole-
genome sequencing was carried out using the Illumina HiSeq2000 with 100-base paired-end
reads. Paired-end reads were mapped against the core chromosome of the ST8 USA300 refer-
ence genome sequence FPR3757 (accession NC_02952) [52]. SNPs and indels were identified
as described previously [53]. ENA accession numbers are listed in S1 Table. We conducted a
quantitative association study on a set of 134 USA300 isolates to identify SNPs that were signif-
icantly associated with toxicity, using the PLINK software package (http://pngu.mgh.harvard.
edu/purcell/plink/) [54]. These and a description of the loci are listed in S2 Table.
Staphylococcus aureus Toxicity Virulence
PLOS Biology | DOI:10.1371/journal.pbio.1002229 September 2, 2015 14 / 21
Maximum Likelihood Tree
This was estimated using PhyML with an HKY85 substitution model, empirical nucleotide
usage, no rate heterogeneity, and no invariant sites. The percentage toxicity range was divided
by three, where the most toxic isolates were labelled red, the midtoxicity isolates labelled
orange, and the least toxic isolates labelled green.
Endothelial Invasion Assay
Bacterial invasion of EA. Hy926 endothelial cells were performed as described previously with
minor modifications [55]. Endothelial cells were cultured in Dulbecco’s modified Eagles’
medium (DMEM) supplemented with 10% FBS and 2 mM L-glutamine at 37°C in a humidi-
fied incubator with 5% CO2. Cells were liberated using trypsin-EDTA solution, resuspended in
culture medium, and aliquoted into 24-well tissue culture tissue plates and grown to>95%
confluence. Cells were washed twice in tissue-grade PBS, and 450 μL of fresh DMEM was
added. 50 μL of washed S. aureus (1 x 107 CFU/mL) was added to the wells and incubated for
1 h at 37°C. Following incubation, the medium was aspirated and wells gently washed once in
PBS and replaced with DMEM supplemented with 200 μg/mL gentamicin and incubated at
37°C for a further 60 min. Cells were subsequently lysed by the addition of 500 μL of Triton
X-100, and bacterial CFU were enumerated by serial dilution of endothelial cell lysates and
plating onto TSA plates and incubated at 37°C overnight. Experiments were performed in
duplicate three times, and the error represents the 95% confidence interval.
Formation of Neutrophil Extracellular Traps and Neutrophil Lysis Assay
Whole blood was obtained from healthy volunteers; ethical permission for all donations was
obtained from a local research ethics committee (School of Pharmacy & Pharmaceutical Sciences
Ethics Committee), and all participants gave written informed consent. Human neutrophils were
isolated as previously described [56]. Cell-free supernatants from bacterial culture were diluted to
30% in warm Krebs buffer and then diluted 1:1 with prewarmed neutrophils (106 neutrophils/mL
in Krebs) and incubated at 37°C for 12 min. Cells were pelleted, and NET formation was quantified
by measuring DNA content in the supernatant with Sytox Green and a DNA standard curve. Any
signal from the bacterial culture was measured and subtracted from these values. For the neutrophil
lysis assay, 20 μL of purified neutrophils was incubated with 20 μL of 10% bacterial supernatant for
15 min, and cell viability was assayed using Guava viability reagent and Guava flow cytometry.
Protease Assay
Amodified tryptic soy agar medium was made with 10% skim milk. 50 μL of bacterial superna-
tant harvested from overnight cultivation was inoculated into 1 cm diameter wells perforated
into the agar medium and incubated for 18 h at 37°C. The digested substrate, as a result of pro-
teolytic activity, was observed as clear areas surrounding the wells, was measured. Protease
assay were done in duplicate, three times, and error represents the 95% confidence interval.
Antimicrobial Peptide Resistance
Purified human neutrophil defensin-1 (hNP-1) was purchased from AnaSpec Incorporated
(California, USA). The hNP-1 susceptibility assay was performed in 1% BHI with the addition
of 10 mM potassium phosphate buffer as described previously [57]. A final inoculum of 105
CFU, with a peptide concentration of 5 μg/mL, was employed and incubated for 2 h at 37°C.
Final bacterial concentration was evaluated by serial plating onto TSA plates and data repre-
sented as mean (± SD) percent survival CFU/mL.
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Biofilm Formation
Semiquantitative measurements of biofilm formation on 96-well polystyrene plates was deter-
mined based on the method of Ziebuhr et al [58]. Overnight bacteria grown in TSB were diluted
1:40 into 100 μL TSB containing 1% glucose and grown for 24 h at 37°C. Following 24-h growth,
plates were washed vigorously five times in PBS, dried and stained with 150 μL of 1% crystal vio-
let for 30 min at room temperature. Following five washes of PBS, wells were resuspended in
200 μL of 7% acetic acid, and optical density at 595 nm was recorded using a plate reader.
Relative Fitness Assay
S. aureus isolates were grown overnight in BHI broth to an OD600 of 2.0 to ensure that all cells
are in a similar physiological state at the start of the experiment. Competitions were established
in TSB with and without 5% (vol/vol) freshly drawn human serum. The competition medium
was inoculated with 104 CFU/mL of the marker strain (MSSA466, which is tetracycline resis-
tant) and 103 CFU/mL of the test strain. Initial cell numbers were confirmed by plating. The
bacteria were competed at 37°C in a shaking incubator (180 rpm) for 24 h. Final cell numbers
were enumerated by serial dilutions on TSA plates (total cell count) and TSA plates containing
2 μg/mL tetracycline (marker strain count). The fitness of a strain was defined as a measure of
the reproductive success of the population, which can be expressed as the natural logarithm of
the ratio of the final and initial cell densities of the culture [59]. Each clinical strain was assayed
once as each was considered a biological replicate indicative of its group.
relative ðDarwinianÞ fitness ¼ lnðAð1Þ=Að0ÞÞ
lnðMð1Þ=Mð0ÞÞ
where: A(0), estimated density of test strain at time 0;M(0), estimated density of marker strain
at time 0; A(1), estimated density of test strain at time 1 d;M(1), estimated density of marker
strain at time 1 d; ln, natural logarithm (logarithm to the base e).
Mathematical Model
We used a simple transmission model to examine the qualitative effect of toxicity-dependent
probabilities of S. aureus to cause invasive disease (see S4 Fig for a flow diagram). We consid-
ered two different strains, distinguished by their level of toxicity (high, h, and low, l), and
assumed that susceptible individuals, S, become colonised with strain i (I = h,l) upon contact
with either colonised or infected individuals (Ci and Ii) with transmission rates βc and βi,
respectively. Individuals transition from colonisation to infection (i.e., SSTI) at a rate δi, from
which they either recover (at rate τi and ρi, accounting for both treatment and immune medi-
ated clearance) or go on to develop invasive diseases (bacteraemia, Bi), with probability σi,
which we assume does not contribute to transmission. The model can then be given by the fol-
lowing set of differential equations for the proportions of the population being susceptible, col-
onised, infected, or suffering from invasive disease:
dS
dt
¼ m Sðll þ lhÞ þ tlIl þ thIh  mS
dCh
dt
¼ lhSþ %hIh  ðmþ dhÞCh  nCh
dCl
dt
¼ llSþ %lIl  ðmþ dlÞCl þ nCh
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dIh
dt
¼ dhCh  %hIh  ðmþ sh þ thÞIh  nIh
dIl
dt
¼ dlCl  %lIl  ðmþ sl þ tlÞIl þ nIh
dBi
dt
¼ siIi  ðmþ wÞBi; i ¼ h; l
with the force of infection of strain i, λi = βCCi + βiIi., disease-induced mortality χ, and μ as the
natural birth/death rate. For simplicity, we did not allow for co- or superinfections but consid-
ered within-host evolution whereby more toxic strains can mutate (at a rate ν) towards lower
levels of toxicity. Within this system, the probability of colonised individuals to develop infec-
tions (SSTI’s) was assumed to be positively correlated with the strain’s degree of toxicity (with
δh> δl), as were the transmission and treatment rates of infected individuals (i.e., βh> βl, τh>
τl). For illustration purposes only, we assumed that when the strains have equal probabilities to
develop invasive disease (i.e., σ1 = σ2), the less toxic strain has a higher ﬁtness than the more
toxic one. That is, we assumed that the less toxic strain is at an optimum, whereby toxicity-
driven increases in transmissibility would be offset by higher clearance rates. Unless stated oth-
erwise, we used the following parameter values: μ = 0.017, βC = 0.05, βl = 4, βh = 4.4, δl = 2, δh =
2.2, τl = 3, τh = 3.3, ρl = ρh = 10, ν = 0.002, χ = 5.
Supporting Information
S1 Data. A file containing three spreadsheets with the toxicity data for the clinical isolates
used in this study, illustrated in Fig 1.
(XLSX)
S2 Data. A spreadsheet containing the toxicity data for the transposon mutants used in this
study, illustrated in Fig 2.
(XLSX)
S3 Data. An excel file containing five spreadsheets with the cell invasion, NETs, biofilm,
hNP1 resistance, and protease activity for subset of isolates, illustrated in Fig 4.
(XLSX)
S4 Data. A spreadsheet containing the relative fitness data for the isolates tested here with
and without human serum, illustrated in Fig 5.
(XLSX)
S5 Data. An excel file containing two spreadsheets with the toxicity data for a range of S.
aureus toxin mutants and purified toxins; and comparing toxicity using T2 cells and fresh
human neutrophils, illustrated in S1 Fig.
(XLSX)
S6 Data. A spreadsheet containing growth dynamic data for high- and low-toxicity isolates
with and without human serum, illustrated in S2 Fig.
(XLSX)
S1 Fig. T2 cell susceptibility to S. aureus cytolytic toxins. A: Using a combination of isogenic
mutant strains and purified toxins, the susceptibility of the T2 cell line is illustrated. Mean of
six replicates are presented, error bars represent the 95% confidence intervals,  indicates
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statistically significant differences. B: The toxicity to both T2 cells and neutrophils of subset of
six high- and six low-toxicity isolates from the single-patient collection was quantified. The
effect of the low-toxicity isolates on cell death does not vary when fresh human neutrophils
that are susceptible to LukAB and LukED are used. To access this data, see S5 Data.
(TIF)
S2 Fig. Growth dynamics of 10 high- and 10 low-toxicity isolates in BHI with and without
5% (vol/vol) human serum. To access this data, see S6 Data.
(TIF)
S3 Fig. Toxicity- and bacteraemia-dependent fitness landscape. A strain's fitness, here
shown as its force of infection at equilibrium, is determined by its level of toxicity and its pro-
pensity to cause bacteraemia. Due to an evolutionary trade-off between toxicity-driven increase
in transmissibility and treatment rate, fitness initially increases with enhanced toxicity but then
declines as individuals become more likely to seek treatment faster, thus limiting the opportu-
nity for onward transmission. With equal probabilities to cause bacteraemia (scenario 1), a
more toxic strain (red) can therefore be outcompeted by a strain with lower levels of toxicity
(green). In contrast, by assuming an inverse correlation between toxicity and the probability of
causing bacteraemia (scenario 2), the more toxic strain can gain a competitive advantage, lead-
ing to the exclusion of the less toxic strain.
(TIF)
S4 Fig. Flow diagram illustrating the dynamical processes underlying the mathematical
model. The population is subdivided into different classes representing those susceptible (S),
colonised with strain i (C_i), infected (SSTI) with strain i (I_i), and those bacteraemic (B_i).
(TIF)
S1 Table. S. aureus isolates used in the study.
(DOCX)
S2 Table. List of SNPs associated with changes in toxicity as determined by PLINK. SNP
site: number corresponds to the distance from the origin of replication. Gene: gene in which
the toxicity-associated SNP resides. Description: known activity of the gene. AA change: amino
acid change caused by the SNP. Tn mutant: name of the Tn mutant obtained from the
Nebraska library in the relevant gene. Bold font indicates Tn mutants with functionally verified
effect on toxicity.
(DOCX)
S3 Table. Clinical features of the bacteraemic isolates used in this study.
(DOCX)
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